Biora Therapeutics, Inc. (BIORQ) — Financial Flexibility Index
Biora Therapeutics, Inc. (BIORQ) has a Financial Flexibility Index of -0.07x as of September 2024. Free cash flow of $-8.71 Million (operating CF $-8.73 Million minus capex $19.00K) represents 0% of total liabilities ($121.13 Million). Also explore Biora Therapeutics, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biora Therapeutics, Inc. Financial Flexibility Index (2018–2023)
Historical Financial Flexibility Index trend for Biora Therapeutics, Inc. across 6 annual periods. For the full cash flow conversion analysis, see Biora Therapeutics, Inc. (BIORQ) cash conversion ratio.
Annual Financial Flexibility Index for Biora Therapeutics, Inc. (2018–2023)
Year-by-year free cash flow to debt coverage for Biora Therapeutics, Inc.. Explore Biora Therapeutics, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.36x | $-48.40 Million | $-48.50 Million | $132.64 Million | ▲ +10.6% |
| 2022 | -0.41x | $-63.62 Million | $-64.42 Million | $155.81 Million | ▲ +52.5% |
| 2021 | -0.86x | $-166.63 Million | $-167.49 Million | $193.81 Million | ▼ -39.8% |
| 2020 | -0.62x | $-160.80 Million | $-165.74 Million | $261.43 Million | ▼ -11.5% |
| 2019 | -0.55x | $-102.40 Million | $-106.12 Million | $185.60 Million | ▼ -40.3% |
| 2018 | -0.39x | $-60.29 Million | $-65.13 Million | $153.37 Million | — |